Investor's Business Daily on MSN20h
Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1Novo Nordisk stock slipped 1.2% to 69.30. Novo Nordisk Is On A Licensing Spree. This is the second big weight-loss deal from Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback